Case studies week 3 pharm

1. Read the uploaded case studies

2. Eacha case study should be answered separately

3. write a 1- 2 pages paper with separated answers in APA format.

Case Study 1

Please address all FOUR case studies. All need to be completed in paragraph format and make sure that your answers are in

complete sentences and in APA format.

1. P.N. is a 28 year-old man who has a B/P of 140/100 mmHg. What is the primary problem? What subjective and objective

data support the problem, and what additional subjective and objective data are not provided but usually are needed to

define this particular problem?
2. D.L. is a 36-year-old construction worker who tripped on a board at the construction site 2 days ago, sustaining an

abrasion of his left shin. He presents to the emergency department with pain, redness, and swelling in the area of the

injury. He is diagnosed as having cellulitis. What is the primary problem? What subjective and objective data support the

problem? What additional subjective and objective data are not provided but usually are needed to define this particular

problem?
3. C.S. is a 58-year-old woman who has had complaints of fatigue, ankle swelling, and SOB, especially when lying down,

for the past week. Physical examination shows distended neck veins, bilateral rales, and S3 gallop rhythm, and lower

extremity edema. A chest radiograph shows an enlarged heart. She is diagnosed as having HF and is being treated with

furosemide and digoxin. What is/are the primary problem(s)? What subjective and objective data support the problem(s)?

What additional subjective and objective data are not provided but usually are needed to define this (these) particular

READ ALSO :   Lab Guidelines

problem(s)?
4. J.O. is a 46 year-old-woman with a 32-pack/year history of cigarette smoking, presents with increasing shortness of

breath. She quit smoking 2 years ago. The chronic cough that she previously had lessened after smoking cessation but the

dyspnea is now somewhat worse, despite use of an albuterol inhaler on a PRN basis. On examination, mild wheezing is

noted. A CXR is unremarkable. Office Spirometry demonstrates an FEV1/FVC of 0.54 and an absolute FEV 1 of 2.0 L or 60% of

predicted. Postboronchodilator treatment demonstrated an FEV 1 increase by 100 mL, 5% increase. How should J.O. be

treated?

Five years later, she has been doing reasonably well. She now presents to your clinic with difficulty carrying laundry up

from her basement and she has noticed that her overall activity level has been curtailed. Repeat office spirometry now

shows an FEV 1/FVC of 0.49 and an absolute FEV1 of 49% of predicted. What therapeutic intervention (s) should be

considered at this point?

She calls you the next day, having read something on the internet regarding possible increased risk of death in people

with obstructive lung disease who take long acting bronchodilators. She is reluctant to take it. What should you tell

her?

J.O. also wonders if anything else other than her medication can be done for her. What advice might be given?

Case studies taken from:
Koda-Kimble, M., Young, L., Alldredge, B., Corelli, R., Guglielmo, B., Kradjan, W., & Williams, B. (2009). Applied

therapeutics: The clinical use of drugs. (9th ed.) Philadelphia, PA: Lippincott, Williams and Wilkins
Place this order with us and get 18% discount now! to earn your discount enter this code: special18 If you need assistance chat with us now by clicking the live chat button.